The Australasian Kidney Trials Network is inviting people with experience of chronic kidney disease to participate in a consumer focus group to gather opinions on
Category: Uncategorized
International Clinical Trial Day 20 May 2021.
This week on May 20 we celebrate International Clinical Trials Day. This day commemorates the day James Lind started his study to determine the cause
The AKTN response to the covid-19 pandemic
The unprecedented demand placed on healthcare systems from the COVID-19 pandemic has forced a reassessment of clinical trial conduct and feasibility. Consequently, the AKTN had
No benefit from drug used to reduce heart disease in kidney patients
A large-scale clinical trial finds lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.The drug is routinely
BEST-Fluids study – recruitment complete
We are delighted to announce that recruitment for BEST-Fluids is now complete, with 808 participants enrolled. Congratulations to all the study teams for your hard
MRFF funding success
The IMPEDE-PKD and M-FIT trials have been successful in receiving funding via the Medical Research Future Fund (MRFF) rare cancers, rare diseases and unmet needs